. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation..
.
.

.
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.